Primary Site >> Liver Cancer
Gene >> BIRC5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Survivin promotes cell proliferation in human hepatocellular carcinoma. PMID: 10796883 |
Ref: Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. PMID: 11854600 Ref: Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. PMID: 12374680 Ref: Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. PMID: 12404288 Ref: Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. PMID: 12433278 |
Ref: Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. PMID: 12582023 Ref: [The signal transduction pathway related to hepatocellular carcinoma apoptosis induced by survivin antisense oligonucleotide]. PMID: 12820923 Ref: Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. PMID: 14508512 Ref: Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. PMID: 14613989 Ref: Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth? PMID: 14652813 Ref: [Inhibition of survivin expression in liver cancer cells by shRNA]. PMID: 14697128 |
Ref: Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. PMID: 14992744 Ref: Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation. PMID: 15067380 Ref: Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. PMID: 15195112 Ref: Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma. PMID: 15547736 Ref: Expression of IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells. PMID: 15650254 |
Ref: Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721. PMID: 15655839 Ref: In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma. PMID: 15698402 Ref: Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation. PMID: 15722574 Ref: Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. PMID: 15880566 Ref: Effect of siRNA targeting survivin gene on the biological behavior of hepatocellular carcinoma. PMID: 15934307 Ref: Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors. PMID: 15958646 Ref: Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma. PMID: 15991282 Ref: Effects of alpha fetoprotein on escape of Bel 7402 cells from attack of lymphocytes. PMID: 16080799 Ref: Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. PMID: 16142326 Ref: Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues. PMID: 16173017 Ref: The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma. PMID: 16270528 Ref: [Use of 99mTc-survivin antisense oligonucleotide in diagnosis of hepatocellular carcinoma: an experiment with mice]. PMID: 16321225 |
Ref: Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin. PMID: 16315030 Ref: P120ctn overexpression enhances beta-catenin-E-cadherin binding and down regulates expression of survivin and cyclin D1 in BEL-7404 hepatoma cells. PMID: 16534869 Ref: Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model. PMID: 16543917 Ref: Oncolytic adenovirus-mediated E1A gene therapy induces tumor-cell apoptosis and reduces tumor angiogenesis leading to inhibition of hepatocellular carcinoma growth in animal model. PMID: 16918299 Ref: [A mini-review of targeting gene-virotherapy of cancer]. PMID: 17059786 Ref: A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. PMID: 17087938 Ref: Expression of Aurora-B kinase and phosphorylated histone H3 in hepatocellular carcinoma. PMID: 17094487 Ref: A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides. PMID: 17149362 Ref: [Expression and clinical significance of certain apoptosis and angiogenesis factors in hepatocellular carcinoma]. PMID: 17359695 |
Ref: A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment. PMID: 17173139 Ref: Transcriptional regulatory regions of the survivin gene activate an exogenous suicide gene in human tumors and enhance the sensitivity to a prodrug. PMID: 17352220 Ref: Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells. PMID: 17603279 Ref: Heavy ion beams induce survivin expression in human hepatoma SMMC-7721 cells more effectively than X-rays. PMID: 17687492 Ref: Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. PMID: 17804728 Ref: Effects and mechanisms of silibinin on human hepatoma cell lines. PMID: 17879397 Ref: Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition. PMID: 17879398 Ref: Relationship between survivin expression and recurrence, and prognosis in hepatocellular carcinoma. PMID: 18069771 Ref: [Dynamic expression of survivin during hepatocarcinogenesis in rats]. PMID: 18246794 Ref: Survivin gene expression in chronic liver disease and hepatocellular carcinoma. PMID: 18251156 |
Ref: WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers. PMID: 18035333 Ref: [Expression of survivin, p27 and PTEN in hepatocellular carcinoma and their clinical significances]. PMID: 18226337 Ref: A survivin double point mutant has potent inhibitory effect on the growth of hepatocellular cancer cells. PMID: 18296918 Ref: Progressive changes in hepatoma cells stably transfected with hepatitis B virus X gene. PMID: 18334850 Ref: Survivin, the promising target in hepatocellular carcinoma gene therapy. PMID: 18364566 Ref: Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. PMID: 18364678 Ref: [Expressions of Survivin and vascular endothelial growth factor in hepatocellular carcinoma and their clinical significance]. PMID: 18504198 Ref: [Effect of siRNA targeted against survivin on the malignant behaviors of human hepatoma cells]. PMID: 18510850 Ref: Anticancer drugs are synergistic with freezing in induction of apoptosis in HCC cells. PMID: 18586021 Ref: Caveolin-1 promotes the transformation and anti-apoptotic ability of mouse hepatoma cells. PMID: 18618588 Ref: [Effects of human telomerase reverse transcriptase promoter and survivin promoter in targeted tumor gene therapy]. PMID: 18642790 Ref: [Down-regulation of survivin in growth inhibition of hepatoma cells induced by a selective cyclooxygenase-2 inhibitor]. PMID: 18815458 Ref: [The effect of p21 on transcription of survivin in hepatocellular carcinoma HepG2 cells and its regulation mechanism]. PMID: 19102934 Ref: [Insulin/PI3K signalling pathway regulates the expression of survivin in liver cancer HepG2 cells]. PMID: 19173802 |
Ref: Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma. PMID: 18824293 Ref: Tamoxifen inhibits proliferation and induces apoptosis in human hepatocellular carcinoma cell line HepG2 via down-regulation of survivin expression. PMID: 18993026 Ref: Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma. PMID: 19140237 Ref: Dysregulation of apoptosis in hepatocellular carcinoma cells. PMID: 19195051 Ref: Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. PMID: 19399925 Ref: Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies. PMID: 19405109 Ref: The basal body gene, RPGRIP1L, is a candidate tumour suppressor gene in human hepatocellular carcinoma. PMID: 19410446 Ref: Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism. PMID: 19461054 Ref: Transformation of human liver L-O2 cells mediated by stable HBx transfection. PMID: 19578387 Ref: Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. PMID: 19778454 Ref: [Survivin antisense oligodeoxynucleotides inhibits the proliferation of hepatocellular carcinoma cells and enhances the cell chemosensitivity to 5-Fu]. PMID: 19923081 Ref: The Value of Survivin Gene and Proliferation of Hepatocytes in Screening for Hepatocellular Carcinoma. PMID: 27990202 |
Ref: Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma. PMID: 19780956 Ref: The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model. PMID: 19846217 Ref: Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice. PMID: 19876077 Ref: Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. PMID: 20099303 Ref: Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma. PMID: 20403046 Ref: Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma. PMID: 20444731 Ref: [Hepatocellular carcinoma--from macroscopy to molecular pathology]. PMID: 20519181 Ref: Hepatitis B virus X protein prevents apoptosis of hepatocellular carcinoma cells by upregulating SATB1 and HURP expression. PMID: 20541537 Ref: Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas. PMID: 20811701 Ref: Prognostic significance of co-expression of nm23 and p57 protein in hepatocellular carcinoma. PMID: 20880063 Ref: Comparison of serum survivin and alpha fetoprotein in Egyptian patients with hepatocellular carcinoma associated with hepatitis C viral infection. PMID: 21133598 |
Ref: Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter. PMID: 21037556 Ref: Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression? PMID: 21108736 Ref: gamma-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent. PMID: 21198544 Ref: Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a Survivin-targeted, amplifiable adenoviral vector. PMID: 21307888 Ref: Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation. PMID: 21312234 Ref: Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. PMID: 21314951 Ref: Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. PMID: 21332389 Ref: Metal-free imidazolium salts inhibit the growth of hepatocellular carcinoma in a mouse model. PMID: 21339744 Ref: Ibulocydine is a novel prodrug Cdk inhibitor that effectively induces apoptosis in hepatocellular carcinoma cells. PMID: 21478145 Ref: Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling. PMID: 21545718 Ref: Potential targets for molecular imaging of apoptosis resistance in hepatocellular carcinoma. PMID: 21655114 Ref: Comparing the efficacy of sunitinib with sorafenib in xenograft models of human hepatocellular carcinoma: mechanistic explanation. PMID: 21834756 Ref: Cancer targeting gene-viro-therapy specific for liver cancer by alpha-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24. PMID: 21835849 Ref: Small interfering RNA-directed targeting of RON alters invasive and oncogenic phenotypes of human hepatocellular carcinoma cells. PMID: 21874262 Ref: Involvement of the NF-kappaB pathway in multidrug resistance induced by HBx in a hepatoma cell line. PMID: 21914061 Ref: HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy. PMID: 22040050 Ref: [Protein expression and significance of survivin and NF-kappaB in hepatocellular carcinoma]. PMID: 22321881 |
Ref: A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect. PMID: 21794078 Ref: Survivin T9809C, an SNP located in 3'-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma. PMID: 22052111 Ref: Deregulation of Hippo kinase signalling in human hepatic malignancies. PMID: 22098159 Ref: Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese han population: a case control study. PMID: 22214342 Ref: Overexpression of tumor suppressor TSLC1 by a survivin-regulated oncolytic adenovirus significantly inhibits hepatocellular carcinoma growth. PMID: 22237452 Ref: Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma. PMID: 22285225 Ref: Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib. PMID: 22322234 Ref: The novel NF-kappaB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. PMID: 22343223 Ref: Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model. PMID: 22387029 Ref: Cyclin-dependent kinase inhibitor 3 is overexpressed in hepatocellular carcinoma and promotes tumor cell proliferation. PMID: 22390936 Ref: No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors. PMID: 22524153 Ref: Co-silencing of Birc5 (survivin) and Hspa5 (Grp78) induces apoptosis in hepatoma cells more efficiently than single gene interference. PMID: 22581315 Ref: Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. PMID: 22610915 Ref: The transcription factor c-Jun protects against liver damage following activated beta-Catenin signaling. PMID: 22792392 Ref: Anti-tumor efficacy of a recombinant human arginase in human hepatocellular carcinoma. PMID: 22873218 Ref: Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. PMID: 23041974 Ref: In vivo induction of apoptosis by fucoxanthin, a marine carotenoid, associated with down-regulating STAT3/EGFR signaling in sarcoma 180 (S180) xenografts-bearing mice. PMID: 23118721 Ref: [Aitongxiao recipe regulated survivin and Bcl- 2 in rats' transplanted hepatoma carcinoma cell]. PMID: 23469606 |
Ref: Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma. PMID: 22318090 Ref: An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma. PMID: 23182495 Ref: Suicide gene therapy for hepatocellular carcinoma cells by survivin promoter-driven expression of the herpes simplex virus thymidine kinase gene. PMID: 23354806 Ref: Effect of Mst1 overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin in vitro. PMID: 23419720 Ref: OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma. PMID: 23433354 Ref: Arsenic trioxide treatment of rabbit liver VX-2 carcinoma via hepatic arterial cannulation-induced apoptosis and decreased levels of survivin in the tumor tissue. PMID: 23444241 Ref: Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3. PMID: 23474115 Ref: Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase. PMID: 23525490 Ref: An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice. PMID: 23922634 Ref: Association of survivin polymorphisms with tumor susceptibility: a meta-analysis. PMID: 24098667 Ref: A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo. PMID: 24195809 Ref: Meta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma. PMID: 24386184 |
Ref: Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies. PMID: 24077840 Ref: Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis. PMID: 24102797 Ref: Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma. PMID: 24409330 Ref: Destruxin B inhibits hepatocellular carcinoma cell growth through modulation of the Wnt/beta-catenin signaling pathway and epithelial-mesenchymal transition. PMID: 24434019 Ref: Ezrin expression and cell survival regulation in colorectal cancer. PMID: 24462708 Ref: GYY4137, a hydrogen sulfide (H(2)S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway. PMID: 24535538 Ref: Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy. PMID: 24613049 Ref: Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathways. PMID: 24675684 Ref: Gene therapy with biosynthetic nanoscale peptide Cecropin A driven by the survivin promoter for hepatocarcinoma cells. PMID: 24804559 Ref: Cracking the cytotoxicity code: apoptotic induction of 10-acetylirciformonin B is mediated through ROS generation and mitochondrial dysfunction. PMID: 24857964 Ref: The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance. PMID: 24885292 Ref: Targeting the Wnt/beta-catenin signaling pathway in liver cancer stem cells and hepatocellular carcinoma cell lines with FH535. PMID: 24940873 Ref: Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model. PMID: 24970807 Ref: MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest. PMID: 24996256 Ref: The expression of Survivin and NF-kappaB associated with prognostically worse clinicopathologic variables in hepatocellular carcinoma. PMID: 24996542 Ref: Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma. PMID: 25238261 Ref: Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-kappaB signaling. PMID: 25240403 Ref: Role and mechanisms of microRNA503 in drug resistance reversal in HepG2/ADM human hepatocellular carcinoma cells. PMID: 25269574 Ref: Preparation of morusin from Ramulus mori and its effects on mice with transplanted H22 hepatocarcinoma. PMID: 25422054 |
Ref: Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models. PMID: 25473902 Ref: Novel synthetic coumarins that targets NF-kappaB in Hepatocellular carcinoma. PMID: 25592709 Ref: Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10. PMID: 25681273 Ref: The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma. PMID: 25714025 Ref: Identifying hub genes and dysregulated pathways in hepatocellular carcinoma. PMID: 25753876 Ref: Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications. PMID: 25754535 Ref: TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis. PMID: 25884709 Ref: Xanthohumol inhibits Notch signaling and induces apoptosis in hepatocellular carcinoma. PMID: 26011160 Ref: Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area. PMID: 26057582 Ref: Survivin is not a promising serological maker for the diagnosis of hepatocellular carcinoma. PMID: 26137069 Ref: Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin. PMID: 26160429 Ref: Downregulation of Vascular Endothelial Growth Factor Enhances Chemosensitivity by Induction of Apoptosis in Hepatocellular Carcinoma Cells. PMID: 26199906 Ref: Oral delivery of shRNA based on amino acid modified chitosan for improved antitumor efficacy. PMID: 26310108 Ref: Folate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma. PMID: 26327128 Ref: Novel carbocyclic curcumin analog CUR3d modulates genes involved in multiple apoptosis pathways in human hepatocellular carcinoma cells. PMID: 26409325 Ref: Expression of USP22 and Survivin is an indicator of malignant behavior in hepatocellular carcinoma. PMID: 26497847 Ref: POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation. PMID: 26510456 Ref: [Matrine enhances the anticancer effect of cisplatin against hepatocellular carcinoma xenografts in nude mice by influencing expression of survivin/caspase-3]. PMID: 26524360 Ref: Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines. PMID: 26617951 |
Ref: Survivin in survival of hepatocellular carcinoma. PMID: 26118774 Ref: Epigenetic regulation of proliferation and invasion in hepatocellular carcinoma cells by CBP/p300 histone acetyltransferase activity. PMID: 26676548 Ref: Artesunate as an Anti-Cancer Agent Targets Stat-3 and Favorably Suppresses Hepatocellular Carcinoma. PMID: 26873192 Ref: Metastasized lung cancer suppression by Morinda citrifolia (Noni) leaf compared to Erlotinib via anti-inflammatory, endogenous antioxidant responses and apoptotic gene activation. PMID: 27106908 Ref: Polysaccharide from Lentinus edodes combined with oxaliplatin possesses the synergy and attenuation effect in hepatocellular carcinoma. PMID: 27130669 Ref: Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol. PMID: 27215551 Ref: The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy. PMID: 27235019 Ref: Alpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitro. PMID: 27255186 Ref: Small-molecule inhibitor sorafenib regulates immunoreactions by inducing survival and differentiation of bone marrow cells. PMID: 27440860 Ref: Oncolytic vaccinia virus inhibits human hepatocellular carcinoma MHCC97-H cell proliferation via endoplasmic reticulum stress, autophagy and Wnt pathways. PMID: 27441866 Ref: Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells. PMID: 27470322 Ref: Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells. PMID: 27485485 Ref: MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells. PMID: 27492460 Ref: Circulating tumour cells as biomarkers for evaluating cryosurgery on unresectable hepatocellular carcinoma. PMID: 27573435 Ref: Inhibitory effect on the proliferation of human heptoma induced by cell-permeable manganese superoxide dismutase. PMID: 27583978 Ref: Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population. PMID: 27650540 Ref: Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells. PMID: 27716619 Ref: Understanding the role of PIN1 in hepatocellular carcinoma. PMID: 28018099 |
Ref: Hepatic Carcinoma Selective Nucleic Acid Nanovector Assembled by Endogenous Molecules Based on Modular Strategy. PMID: 28035828 Ref: Knockdown of COBRA1 decreases the proliferation and migration of hepatocellular carcinoma cells. PMID: 28112367 Ref: A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma. PMID: 28187036 Ref: Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence. PMID: 28238542 Ref: From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma. PMID: 28316892 Ref: Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy. PMID: 28330473 Ref: Study on the mechanism of AMPK signaling pathway and its effect on apoptosis of human hepatocellular carcinoma SMMC-7721 cells by curcumin. PMID: 28338175 Ref: Magnetic Cationic Amylose Nanoparticles Used to Deliver Survivin-Small Interfering RNA for Gene Therapy of Hepatocellular Carcinoma In Vitro. PMID: 28492491 Ref: Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma. PMID: 28714512 Ref: Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer. PMID: 28900506 Ref: Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy. PMID: 28948461 Ref: [Expression of P16 and survivin in liver cancer and their clinical significance]. PMID: 29108210 Ref: MiR-3613-3p affects cell proliferation and cell cycle in hepatocellular carcinoma. PMID: 29190974 |
Ref: Antiproliferative activity of vitexin-2-O-xyloside and avenanthramides on CaCo-2 and HepG2 cancer cells occurs through apoptosis induction and reduction of pro-survival mechanisms. PMID: 28283822 Ref: Deep Learning-Based Multi-Omics Integration Robustly Predicts Survival in Liver Cancer. PMID: 28982688 Ref: Downregulation of Survivin Gene Expression Affects Ionizing Radiation Resistance of Human T98 Glioma Cells. PMID: 29098505 Ref: Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway. PMID: 29253760 Ref: Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens. PMID: 29497780 Ref: Glycycoumarin Sensitizes Liver Cancer Cells to ABT-737 by Targeting De Novo Lipogenesis and TOPK-Survivin Axis. PMID: 29543705 Ref: Survivin-targeted drug screening platform identifies a matrine derivative WM-127 as a potential therapeutics against hepatocellular carcinoma. PMID: 29608986 Ref: An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients. PMID: 29707114 Ref: MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma. PMID: 29710480 Ref: The Possible Mechanisms of HSV-TK/Hyperthermia Combined with 131I-antiAFPMcAb-GCV Nanospheres to Treat Hepatoma. PMID: 29854577 Ref: Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3beta/beta-catenin pathway. PMID: 29859044 Ref: Oct4 promotes cancer cell proliferation and migration and leads to poor prognosis associated with the survivin/STAT3 pathway in hepatocellular carcinoma. PMID: 29901157 Ref: Expressions and correlation analysis of HIF-1alpha, survivin and VEGF in patients with hepatocarcinoma. PMID: 29917189 Ref: Diagnostic Value of the Survivin Autoantibody in Four Types of Malignancies. PMID: 29924656 Ref: Insulin-like growth factor-1 induces epithelial-mesenchymal transition in hepatocellular carcinoma by activating survivin. PMID: 29989646 Ref: Correlations of MRI manifestations with survivin gene expression in primary hepatic carcinoma. PMID: 30010107 Ref: Microarray gene expression profiling in colorectal (HCT116) and hepatocellular (HepG2) carcinoma cell lines treated with Melicope ptelefolia leaf extract reveals transcriptome profiles exhibiting anticancer activity. PMID: 30042885 Ref: Licochalcone A from licorice root, an inhibitor of human hepatoma cell growth via induction of cell apoptosis and cell cycle arrest. PMID: 30055311 Ref: Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway. PMID: 30146257 Ref: Novel 1,4-dihydropyridine induces apoptosis in human cancer cells through overexpression of Sirtuin1. PMID: 30203236 Ref: A Combination of Moringin and Avenanthramide 2f Inhibits the Proliferation of Hep3B Liver Cancer Cells Inducing Intrinsic and Extrinsic Apoptosis. PMID: 30204484 Ref: Inhibition of SRC/FAK cue: A novel pathway for the synergistic effect of rosuvastatin on the anti-cancer effect of dasatinib in hepatocellular carcinoma. PMID: 30292831 |